{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:40:11Z","timestamp":1760910011593,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Rajendra Memorial Research Institute of Medical Sciences"},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cyto.2020.155208","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T10:32:55Z","timestamp":1595932375000},"page":"155208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dendritic cell engineered cTXN as new vaccine prospect against L. donovani"],"prefix":"10.1016","volume":"145","author":[{"given":"Shashi S.","family":"Suman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Amit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Topno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.N.R.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8392-035X","authenticated-orcid":false,"given":"Vahab","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-7155","authenticated-orcid":false,"given":"Sanjiva","family":"Bimal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cyto.2020.155208_b0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"6\u20137","key":"10.1016\/j.cyto.2020.155208_b0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365540410020451","article-title":"An emerging peri-urban pattern of infection with Leishmaniachagasi, the protozoan causing visceral leishmaniasis in northeast Brazil","volume":"36","author":"Jeronimo","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment\u2014a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cyto.2020.155208_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.cyto.2020.155208_b0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0966-842X(03)00075-1","article-title":"Neutrophil granulocytes\u2013Trojan horses for Leishmaniamajor and other intracellular microbes?","volume":"11","author":"Laskay","year":"2003","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13071-016-1540-3","article-title":"The site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermis","volume":"9","author":"de Menezes","year":"2016","journal-title":"Parasites Vectors"},{"issue":"91","key":"10.1016\/j.cyto.2020.155208_b0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cyto.2017.01.001","article-title":"Adenosine generated by ectonucleotidases modulates the host immune system during visceral leishmaniasis","volume":"1","author":"Vijayamahantesh","year":"2017","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cyto.2020.155208_b0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0169-4758(00)01692-6","article-title":"Leishmania\u2013host-cell interaction: complexities and alternative views","volume":"16","author":"Rittig","year":"2000","journal-title":"Parasitol. Today"},{"issue":"2","key":"10.1016\/j.cyto.2020.155208_b0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CMR.18.2.293-305.2005","article-title":"Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view","volume":"18","author":"Olivier","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2020.155208_b0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155208_b0055","first-page":"131","article-title":"Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar","volume":"18","author":"Das","year":"2005","journal-title":"National Med. J. India"},{"issue":"3","key":"10.1016\/j.cyto.2020.155208_b0060","first-page":"59","article-title":"Visceral leishmaniasis as a possible reason for pancytopenia","volume":"29","author":"Koster","year":"2015","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.cyto.2020.155208_b0065","series-title":"Overview of Leishmaniasis with Special Emphasis on Kala-azar in South Asia. In Neglected Tropical Diseases-South Asia","first-page":"1","author":"Chang","year":"2017"},{"issue":"3","key":"10.1016\/j.cyto.2020.155208_b0070","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/IAI.00611-07","article-title":"gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB\/c mice infected with Leishmaniadonovani","volume":"76","author":"Bhowmick","year":"2008","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cyto.2020.155208_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J. Global Infect. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpara.2014.08.013","article-title":"Leishmaniadonovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis","volume":"45","author":"Yadav","year":"2015","journal-title":"Int. J. Parasitol."},{"issue":"82","key":"10.1016\/j.cyto.2020.155208_b0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmaniadonovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb\/c mice","volume":"1","author":"Amit","year":"2017","journal-title":"Mol. Immunol."},{"issue":"03","key":"10.1016\/j.cyto.2020.155208_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4236\/mri.2017.63003","article-title":"A new vaccine strategy of dendritic cell presented kinetoplastid membrane (KMP-11) as immunogen for control against experimental visceral leishmaniasis","volume":"6","author":"Chaudhary","year":"2017","journal-title":"Modern Res. Inflam."},{"key":"10.1016\/j.cyto.2020.155208_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/947606","article-title":"Immunomodulation in human dendritic cells leads to induction of interferon-gamma production by leishmaniadonovani derived KMP-11 antigen via activation of NF-B in indian kala-azar patients","volume":"2014","author":"Chaudhary","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.cyto.2020.155208_b0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.exppara.2005.05.009","article-title":"Leishmaniadonovani: effect of therapy on expression of CD2 antigen and secretion of macrophage migration inhibition factor by T-cells in patients with visceral leishmaniasis","volume":"111","author":"Bimal","year":"2005","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155208_b0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0952-7915(02)00353-9","article-title":"Dendritic cells and immunity to leishmaniasis and toxoplasmosis","volume":"14","author":"Scott","year":"2002","journal-title":"Curr. Opin. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2020.155208_b0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.imbio.2004.02.007","article-title":"Interaction of Leishmania parasites with dendritic cells and its functional consequences","volume":"209","author":"Ghosh","year":"2004","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12026-013-8389-8","article-title":"The immunology of Leishmania\/HIV co-infection","volume":"56","author":"Okwor","year":"2013","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.cyto.2020.155208_b0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molbiopara.2004.02.015","article-title":"Two linked genes of Leishmania infantum encode tryparedoxins localised to cytosol and mitochondrion","volume":"136","author":"Castro","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"issue":"121","key":"10.1016\/j.cyto.2020.155208_b0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biochi.2015.12.017","article-title":"Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmaniadonovani and its interaction with cytosolic tryparedoxin peroxidase","volume":"1","author":"Suman","year":"2016","journal-title":"Biochimie"},{"issue":"108","key":"10.1016\/j.cyto.2020.155208_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2018.03.010","article-title":"Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis","volume":"1","author":"Suman","year":"2018","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.cyto.2020.155208_b0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/abbi.2001.2688","article-title":"Tryparedoxin peroxidase of Leishmaniadonovani: molecular cloning, heterologous expression, specificity, and catalytic mechanism","volume":"397","author":"Floh\u00e9","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"issue":"9\u201310","key":"10.1016\/j.cyto.2020.155208_b0145","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1089\/ars.2006.8.1391","article-title":"The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control","volume":"8","author":"G\u00f6rlach","year":"2006","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.cyto.2020.155208_b0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00436-007-0784-4","article-title":"Identification and enzymatic activities of four protein disulfide isomerase (PDI) isoforms of Leishmania amazonensis","volume":"102","author":"Hong","year":"2008","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/ars.2009.2529","article-title":"Redox control of endoplasmic reticulum function","volume":"13","author":"Csala","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cyto.2020.155208_b0160","doi-asserted-by":"crossref","unstructured":"A. Kumar, M.R. Dikhit, A. Amit, A. Zaidi, R.K. Pandey, Singh A. Kumar, S.S. Suman, V. Ali, V.N. Das, K. Pandey, S.K. Singh, Immunomodulation induced through ornithine decarboxylase DNA immunization in Balb\/c mice infected with Leishmania donovani, Mol. Immunol. 97 (2018 May 1) 33-44.","DOI":"10.1016\/j.molimm.2018.03.004"},{"issue":"9","key":"10.1016\/j.cyto.2020.155208_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12451","article-title":"Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC)","volume":"39","author":"Dikhit","year":"2017","journal-title":"Parasite Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0952-7915(97)80154-9","article-title":"Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-\u03b3)","volume":"9","author":"Trinchieri","year":"1997","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/eji.200324567","article-title":"Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo","volume":"34","author":"Pulendran","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155208_b0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-3024.1995.tb00888.x","article-title":"IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice","volume":"17","author":"Khan","year":"1995","journal-title":"Parasite Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.0904484","article-title":"New insights into the molecular mechanism of interleukin-10-mediated immunosuppression","volume":"77","author":"Gr\u00fctz","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155208_b0190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/abbi.2001.2688","article-title":"Tryparedoxin peroxidase of Leishmania donovani: molecular cloning, heterologous expression, specificity, and catalytic mechanism","volume":"397","author":"Floh\u00e9","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cyto.2020.155208_b0195","doi-asserted-by":"crossref","unstructured":"R.L. Krauth-Siegel, M.A. Comini, Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism,Biochimica et Biophysica Acta (BBA)-General Subjects 1780(11) (2008 Nov 1) 1236-48.","DOI":"10.1016\/j.bbagen.2008.03.006"},{"issue":"63","key":"10.1016\/j.cyto.2020.155208_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2013.04.036","article-title":"Redox metabolism in Trypanosoma cruzi: functional characterization of tryparedoxins revisited","volume":"1","author":"Arias","year":"2013","journal-title":"Free Radical Biol. Med."},{"issue":"10","key":"10.1016\/j.cyto.2020.155208_b0205","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1089\/ars.2011.4322","article-title":"Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance","volume":"18","author":"Lee","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.cyto.2020.155208_b0210","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/JCM.02402-09","article-title":"Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis","volume":"48","author":"Santar\u00e9m","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.cyto.2020.155208_b0215","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmaniadonovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.cyto.2020.155208_b0220","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection","volume":"52","author":"Basu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.cyto.2020.155208_b0225","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/CVI.05024-11","article-title":"KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis","volume":"18","author":"Goto","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"19","key":"10.1016\/j.cyto.2020.155208_b0230","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+ MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.cyto.2020.155208_b0235","doi-asserted-by":"crossref","unstructured":"R. Guha, D. Gupta, R. Rastogi, R. Vikram, G. Krishnamurthy, S. Bimal, S. Roy, A. Mukhopadhyay, Vaccination with leishmania hemoglobin receptor\u2013encoding DNA protects against visceral leishmaniasis, Science Translational Medicine 5(202) (2013 Sep 11) 202ra121-.","DOI":"10.1126\/scitranslmed.3006406"},{"issue":"4","key":"10.1016\/j.cyto.2020.155208_b0240","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/IAI.70.4.2151-2158.2002","article-title":"Early enhanced Th1 response after Leishmaniaamazonensis infection of C57BL\/6 interleukin-10-deficient mice does not lead to resolution of infection","volume":"70","author":"Jones","year":"2002","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.cyto.2020.155208_b0245","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.4049\/jimmunol.171.7.3705","article-title":"The role of interleukin-10 in susceptibility of BALB\/c mice to infection with Leishmaniamexicana and Leishmaniaamazonensis","volume":"171","author":"Padigel","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155208_b0250","doi-asserted-by":"crossref","unstructured":"Vijayamahantesh, A. Amit, M.R. Dikhit, A.K. Singh, T. Venkateshwaran, V.N. Das, P. Das, S. Bimal, Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects, Microbes and infection 19(6) (2017 Jun 1) 358-69.","DOI":"10.1016\/j.micinf.2017.03.002"},{"issue":"1","key":"10.1016\/j.cyto.2020.155208_b0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imr.12035","article-title":"The Th17 family: flexibility follows function","volume":"252","author":"Basu","year":"2013","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.cyto.2020.155208_b0260","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/eji.1830270409","article-title":"Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation","volume":"27","author":"Vouldoukis","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2020.155208_b0265","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.188.11.2175","article-title":"Dendritic cell survival and maturation are regulated by different signaling pathways","volume":"188","author":"Rescigno","year":"1998","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.cyto.2020.155208_b0270","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1093\/emboj\/19.13.3304","article-title":"CD40 signaling in human dendritic cells is initiated within membrane rafts","volume":"19","author":"Vidalain","year":"2000","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.cyto.2020.155208_b0275","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(01)00141-8","article-title":"GADD45\u03b3 mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells","volume":"14","author":"Lu","year":"2001","journal-title":"Immunity"},{"issue":"31","key":"10.1016\/j.cyto.2020.155208_b0280","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","article-title":"Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis","volume":"29","author":"Agallou","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2020.155208_b0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cimid.2017.07.002","article-title":"Alternative strategy for visceral leishmaniosis control: HisAK70-Salmonella Choleraesuis-pulsed dendritic cells","volume":"54","author":"Dom\u00ednguez-Bernal","year":"2017","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2020.155208_b0290","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","article-title":"Vaccine candidates against leishmania under current research","volume":"17","author":"Iborra","year":"2018","journal-title":"Expert review of vaccines"},{"issue":"8","key":"10.1016\/j.cyto.2020.155208_b0295","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/pim.12100","article-title":"Immunoregulation in human American leishmaniasis: balancing pathology and protection","volume":"36","author":"Gollob","year":"2014","journal-title":"Parasite Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:25Z","timestamp":1760907565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620302246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":59,"alternative-id":["S1043466620302246"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155208","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cell engineered cTXN as new vaccine prospect against L. donovani","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155208"}}